Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases

BACKGROUND: Pharmaceutical compounding of orphan active ingredients can offer cost-effective treatment to patients when no other drug product is available for a rare disease or during periods of drug product shortages. Additionally, it allows customized therapy for patients with rare diseases. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanhoorne, V., Peeters, E., Van Tongelen, I., Boussery, K., Wynendaele, E., De Spiegeleer, B., Remon, J. P., Vervaet, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676613/
https://www.ncbi.nlm.nih.gov/pubmed/31370862
http://dx.doi.org/10.1186/s13023-019-1154-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676613/
https://www.ncbi.nlm.nih.gov/pubmed/31370862
http://dx.doi.org/10.1186/s13023-019-1154-x

Ejemplares similares